TGAS ADVISORS LLC – Trademark Portfolio
Entity Type: 16
TGAS ADVISORS LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TGAS and HOW DO OTHER PHARMACEUTICAL COMPANIES DO 'IT'?. The owner is based in EAST NORRITON, PA.
301 EAST GERMANTOWN PIKE
EAST NORRITON, PA 19401
Showing of trademarks Trademarks
Trademark Classifications
TGAS ADVISORS LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does TGAS ADVISORS LLC have?
TGAS ADVISORS LLC has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 cancelled.
What trademark classes does TGAS ADVISORS LLC file in?
TGAS ADVISORS LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 16 (Paper Goods). Class 35 covers advertising; business management; business administration; office functions.
What are TGAS ADVISORS LLC's most well-known trademarks?
TGAS ADVISORS LLC's registered trademark portfolio includes well-known marks such as TGAS and HOW DO OTHER PHARMACEUTICAL COMPANIES DO 'IT'?. These are among 2 currently registered trademarks in the portfolio.
What is TGAS ADVISORS LLC's trademark registration success rate?
TGAS ADVISORS LLC has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.